Vaisala Group
Vaisala Corporation
Managers’ Transactions
March 10, 2021 at 2:45 p.m. (EET)
Vaisala Corporation: Managers’ Transactions - Muurinen, Kaarina
Vaisala Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Muurinen, Kaarina
Position: Chief Financial Officer
Issuer: Vaisala Oyj
LEI: 743700RNDD7KU11HW873
Notification type: INITIAL NOTIFICATION
Reference number: 743700RNDD7KU11HW873_20210308160213_4
____________________________________________
Transaction date: 2021-03-10
Venue not applicable
Instrument type: SHARE
ISIN: FI0009900682
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION
Transaction details
(1): Volume: 8,864 Unit price:
Aggregated transactions
(1): Volume: 8,864 Volume weighted average price:
More information
Kaarina Muurinen, CFO
Tel. +358 40 577 5066
Distribution
Nasdaq Helsinki
Key media
vaisala.com
Vaisala is a global leader in environmental and industrial measurement. Building on over 80 years of experience, Vaisala provides observations for a better world. We are a reliable partner for customers around the world, offering a comprehensive range of innovative observation and measurement products and services. Headquartered in Finland, Vaisala employs over 1,900 professionals worldwide and is listed on the Nasdaq Helsinki stock exchange. vaisala.com twitter.com/VaisalaGroup
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S18.10.2025 12:00:34 CEST | Press release
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
F. Hoffmann-La Roche Ltd18.10.2025 07:00:00 CEST | Press release
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer
StoneX Group Inc.18.10.2025 01:12:36 CEST | Press release
StoneX Expands Wealth Management Offering for Latin American Clients
F. Hoffmann-La Roche Ltd17.10.2025 22:20:00 CEST | Press release
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Eavor Technologies Inc.17.10.2025 18:00:00 CEST | Press release
Mark Fitzgerald Appointed President and Chief Executive Officer of Eavor Technologies Inc.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom